A5075454350- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
- Sensor Technology and Measurement Systems
- Robotics and Automated Systems
- Wireless Sensor Networks for Data Analysis
Ospedale Generale Regionale Francesco Miulli
2022
Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. reported data of the first 5 worldwide, showed no side effects, absence AF episodes and without antiarrhythmic drugs.ClinicalTrials.gov, identifier: NCT04575662.
Abstract Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of general population. Patients affected by AF have an increased risk stroke and heart failure European guidelines recommend catheter ablation symptomatic patients refractory to antiarrhythmic therapy. In elderly patients, procedure associated with a higher rate overall complications. Recently, stereotactic arrhythmia radioablation (STAR) precise high-dose radiation was used treat...